These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2299987

  • 1. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP, Illingworth DR.
    Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
    [Abstract] [Full Text] [Related]

  • 2. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.
    Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J.
    Metabolism; 1993 Jul; 42(7):895-901. PubMed ID: 8345800
    [Abstract] [Full Text] [Related]

  • 3. Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.
    Ojala JP, Helve E, Ehnholm C, Aalto-Setälä K, Kontula KK, Tikkanen MJ.
    J Intern Med; 1991 Nov; 230(5):397-405. PubMed ID: 1940775
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S, Vega GL, Haddox RJ, Dolan ET, Grundy SM.
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [Abstract] [Full Text] [Related]

  • 6. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y, Leitersdorf E.
    Genet Epidemiol; 1996 Oct; 13(2):159-77. PubMed ID: 8722744
    [Abstract] [Full Text] [Related]

  • 7. Familial hypercholesterolemia and apolipoprotein E4.
    Eto M, Watanabe K, Chonan N, Ishii K.
    Atherosclerosis; 1988 Aug; 72(2-3):123-8. PubMed ID: 3214464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R, Real JT, Ascaso JF, Ordovás JM, Carmena R.
    Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy.
    Berglund L, Wiklund O, Eggertsen G, Olofsson SO, Eriksson M, Lindén T, Bondjers G, Angelin B.
    J Intern Med; 1993 Feb; 233(2):173-8. PubMed ID: 8433078
    [Abstract] [Full Text] [Related]

  • 11. Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
    De Knijff P, Stalenhoef AF, Mol MJ, Gevers Leuven JA, Smit J, Erkelens DW, Schouten J, Frants RR, Havekes LM.
    Atherosclerosis; 1990 Jul; 83(1):89-97. PubMed ID: 2390138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR, Bacon S.
    Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
    Vuorio AF, Ojala JP, Sarna S, Turtola H, Tikkanen MJ, Kontula K.
    J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.